Hepatitis C Virus Infection
Author:
Lu Shi,Noiri Eisei
Reference5 articles.
1. Noiri E, Nakao A, Oya A, Fujita T, Kimura S (2001) Hepatitis C virus in blood and dialysate in hemodialysis. Am J Kidney Dis 37:38–42 2. Yamashita T, Arai K, Sakai A, Mizukoshi E, Sakai Y, Kagaya T, Nakamoto Y, Honda M, Wada T, Yokoyama H, Kaneko S (2006) Virological effects and safety of combined double filtration plasmapheresis (DFPP) and interferon therapy in patients with chronic hepatitis C: a preliminary study. Hepatol Res 36:167–175 3. Fujiwara K, Kaneko S, Kakumu S, Sata M, Hige S, Tomita E, Mochida S (2007) Virus Reduction Therapy Study Group: Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load. Hepatol Res 37:701–710 4. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H (1993) Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 67:1953–1958 5. Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F, Toda M, Ito Y, Ohto M (1991) Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 338:914–915
|
|